Study of Adaptation of the Right Ventricle to Systemic Afterload (STARS)
Primary Purpose
Congenital Heart Disease With Systemic Right Ventricle
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
asymptomatic group
symptomatic group
Sponsored by
About this trial
This is an interventional diagnostic trial for Congenital Heart Disease With Systemic Right Ventricle focused on measuring systemic right ventricle, cardiac magnetic resonance imaging, congenital heart disease
Eligibility Criteria
Patients inclusion criteria:
- patients with a systemic right ventricle
- to have an insurance
- to obtain informed consent
Patients non-inclusion criteria:
- patients with cyanosis defined by a saturation ≤ 85% at rest
- patients with a ventricular septal defect non repaired at the time of inclusion
- contraindications normal MRI
- contraindication to achieving a stress test
- Glomerular Filtration Rate inf 30ml/mn/1.73m²
- physical or mental disability that does not allow to perform a cardiopulmonary exercise test
- patients with already severe allergy to gadolinium MRI contrast
- current Pregnancy
- patients who can not be monitored over the period of one year, patient participating in another research on the Treatment interacting with the neurohormonal system in particular the renin-angiotensin-aldosterone system
healthy subjects inclusion criteria:
- matched for age and sex + / - 5 years of an asymptomatic patient
- Normal ECG
- normal Echocardiography
- clinical examination prior
- Patient receiving an insurance
- Obtaining informed consent
healthy subjects Exclusion criteria:
- History of myocardial infarction-known or detectable on the ECG-abnormal Liver function tests
- Complete Blood Count
- electrolytes
- viral serology
- Primary or secondary cardiomyopathy-known or detectable on echocardiography
- History of thoracic radiotherapy or chemotherapy
- Contraindications MRI
- Counter-indication for performing a stress test
- Patient with severe renal clearance less than Glomerular Filtration Rate inf 30ml/mn/1.73m²
- Patient has already made a severe allergy to gadolinium MRI contrast Current Pregnancy
Sites / Locations
- Hôpital Européen Georges Pompidou
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Sham Comparator
Sham Comparator
Sham Comparator
Arm Label
asymptomatic group
symptomatic group
control
Arm Description
patients with systemic right ventricle who are asymptomatic,
symptomatic group : patients with systemic right ventricle and heart failure signs and/or decrease exercise performance
healthy subject matched with patients of asymptomatic group
Outcomes
Primary Outcome Measures
remodelling indexes
wall stress index
fibrosis of systemic RV measured by MRI
Secondary Outcome Measures
echographic measures of RV function and geometry indexes
comparison between patients and healthy subjects and analysis of the evolution of the measured parameters in the 2 groups after one year of follow
Arterial mechanical properties (stiffness aortic distensibility and arterial compliance)
comparison between patients and healthy subjects and analysis of the evolution of the measured parameters in the 2 groups after one year of follow
Rate of neurohormones of the renin-angiotensin-aldosterone system and neuropeptides
Variability and reproducibility indices remodeling and wall stress MRI
inter and intra-observer variability and inter-examination MRI measures
Full Information
NCT ID
NCT02066506
First Posted
September 17, 2013
Last Updated
March 31, 2015
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT02066506
Brief Title
Study of Adaptation of the Right Ventricle to Systemic Afterload
Acronym
STARS
Official Title
Study of Adaptation of the Right Ventricle to Systemic Afterload
Study Type
Interventional
2. Study Status
Record Verification Date
August 2012
Overall Recruitment Status
Completed
Study Start Date
February 2011 (undefined)
Primary Completion Date
February 2013 (Actual)
Study Completion Date
February 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
the first purpose of the study is to determine the adaptative mechanisms of right ventricle (RV) to systemic afterload, and the mechanisms of RV failure, in patients with congenital heart disease and subaortic RV, using cardiac magnetic resonance imaging (CMR).The mechanisms are evaluated by measures of RV remodelling and RV wall stress using CMR. Second objectives are to evaluate these mechanisms using echography, arterial properties study and neurohormonal levels
Detailed Description
Right ventricle (RV) in sub-aortic position is a rare situation, mainly in two congenital heart defects: congenitally corrected transposition of the great arteries and complete transposition of the great arteries palliated by atrial switch. In these patients, increase of afterload leads to hypertrophy and late RV dilatation. The stress exercised on RV walls could play a role in adaptative mechanisms to systemic afterload. Beyond a remodelling threshold, it could cause fibrosis damage and RV systolic failure. Magnetic resonance imaging, which has a major potential in estimation of RV remodelling, wall stress and fibrosis, could shed light on RV adaptation to systemic afterload and evolution towards failure. Systemic RV remodelling and function could also depend on the neuro-hormone secretion and mechanical arterial properties, that have a direct influence on patients afterload. The first purpose of the study is to determine the adaptative mechanisms of RV to systemic afterload, and the mechanisms of RV failure, in patients with congenital heart disease and subaortic RV, using cardiac magnetic resonance imaging (CMR).The mechanisms are evaluated by measures of RV remodelling and RV wall stress using CMR. Second objectives are to evaluate these mechanisms using echography, arterial properties study and neurohormonal levels
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congenital Heart Disease With Systemic Right Ventricle
Keywords
systemic right ventricle, cardiac magnetic resonance imaging, congenital heart disease
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
90 (Actual)
8. Arms, Groups, and Interventions
Arm Title
asymptomatic group
Arm Type
Sham Comparator
Arm Description
patients with systemic right ventricle who are asymptomatic,
Arm Title
symptomatic group
Arm Type
Sham Comparator
Arm Description
symptomatic group : patients with systemic right ventricle and heart failure signs and/or decrease exercise performance
Arm Title
control
Arm Type
Sham Comparator
Arm Description
healthy subject matched with patients of asymptomatic group
Intervention Type
Other
Intervention Name(s)
asymptomatic group
Intervention Description
2 visits with MRI
Intervention Type
Other
Intervention Name(s)
symptomatic group
Intervention Description
2 visits with MRI
Primary Outcome Measure Information:
Title
remodelling indexes
Time Frame
48 months
Title
wall stress index
Time Frame
48 months
Title
fibrosis of systemic RV measured by MRI
Time Frame
48 months
Secondary Outcome Measure Information:
Title
echographic measures of RV function and geometry indexes
Description
comparison between patients and healthy subjects and analysis of the evolution of the measured parameters in the 2 groups after one year of follow
Time Frame
48 months
Title
Arterial mechanical properties (stiffness aortic distensibility and arterial compliance)
Description
comparison between patients and healthy subjects and analysis of the evolution of the measured parameters in the 2 groups after one year of follow
Time Frame
48 months
Title
Rate of neurohormones of the renin-angiotensin-aldosterone system and neuropeptides
Time Frame
48 months
Title
Variability and reproducibility indices remodeling and wall stress MRI
Description
inter and intra-observer variability and inter-examination MRI measures
Time Frame
48 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Patients inclusion criteria:
patients with a systemic right ventricle
to have an insurance
to obtain informed consent
Patients non-inclusion criteria:
patients with cyanosis defined by a saturation ≤ 85% at rest
patients with a ventricular septal defect non repaired at the time of inclusion
contraindications normal MRI
contraindication to achieving a stress test
Glomerular Filtration Rate inf 30ml/mn/1.73m²
physical or mental disability that does not allow to perform a cardiopulmonary exercise test
patients with already severe allergy to gadolinium MRI contrast
current Pregnancy
patients who can not be monitored over the period of one year, patient participating in another research on the Treatment interacting with the neurohormonal system in particular the renin-angiotensin-aldosterone system
healthy subjects inclusion criteria:
matched for age and sex + / - 5 years of an asymptomatic patient
Normal ECG
normal Echocardiography
clinical examination prior
Patient receiving an insurance
Obtaining informed consent
healthy subjects Exclusion criteria:
History of myocardial infarction-known or detectable on the ECG-abnormal Liver function tests
Complete Blood Count
electrolytes
viral serology
Primary or secondary cardiomyopathy-known or detectable on echocardiography
History of thoracic radiotherapy or chemotherapy
Contraindications MRI
Counter-indication for performing a stress test
Patient with severe renal clearance less than Glomerular Filtration Rate inf 30ml/mn/1.73m²
Patient has already made a severe allergy to gadolinium MRI contrast Current Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Magalie Ladouceur, MD
Organizational Affiliation
Université Paris Descartes
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Européen Georges Pompidou
City
Paris
ZIP/Postal Code
75015
Country
France
12. IPD Sharing Statement
Learn more about this trial
Study of Adaptation of the Right Ventricle to Systemic Afterload
We'll reach out to this number within 24 hrs